$6.98
At close: May 30 EDT
$6.99
0.010000.14%
Pre-Market: 7:01 AM EDT
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Exagen Stock Price, Quotes and Forecasts | NASDAQ:XGN | Benzinga
Explore Exagen stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XGN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exagen (XGN) stock?
You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.
Who are Exagen (XGN) competitors?
Other companies in Exagen’s space includes: Molecular Partners (NASDAQ:MOLN), 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Fate Therapeutics (NASDAQ:FATE).
What is the forecast, or price target, for Exagen (XGN) stock?
Exagen has a consensus price target of $6.67.
What is the current price for Exagen (XGN)?
The stock price for Exagen (NASDAQ: XGN) is $6.99 last updated May 30, 2025 at 7:01 AM EDT.
Does Exagen (XGN) pay a dividend?
There are no upcoming dividends for Exagen.
When is Exagen (NASDAQ:XGN) reporting earnings?
Exagen’s Q2 earnings are confirmed for Monday, August 4, 2025.
Is Exagen (XGN) going to split?
There is no upcoming split for Exagen.
What sector and industry does Exagen (XGN) operate in?
Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
